Literature DB >> 15451829

ALLHAT: what has it taught us so far?

Frans H H Leenen1.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15451829      PMCID： PMC517850          DOI： 10.1503/cmaj.1031010

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  7 in total

1.  ALLHAT, or the soft science of the secondary end point.

Authors:  Franz H Messerli
Journal:  Ann Intern Med       Date:  2003-11-04       Impact factor: 25.391

Review 2.  ALLHAT: setting the record straight.

Authors:  Barry R Davis; Curt D Furberg; Jackson T Wright; Jeffrey A Cutler; Paul Whelton
Journal:  Ann Intern Med       Date:  2004-07-06       Impact factor: 25.391

3.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

4.  A new approach for measuring quality of care for women with hypertension.

Authors:  S M Asch; E A Kerr; P Lapuerta; A Law; E A McGlynn
Journal:  Arch Intern Med       Date:  2001-05-28

5.  Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003.

Authors:  Jan A Staessen; Ji-Guang Wang; Lutgarde Thijs
Journal:  J Hypertens       Date:  2003-06       Impact factor: 4.844

6.  Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

Authors:  Fiona Turnbull
Journal:  Lancet       Date:  2003-11-08       Impact factor: 79.321

7.  Validation of Heart Failure Events in the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Participants Assigned to Doxazosin and Chlorthalidone.

Authors:  Linda B Piller; Barry R Davis; Jeffrey A Cutler; William C Cushman; Jackson T Wright; Jeff D Williamson; Frans HH Leenen; Paula T Einhorn; Otelio S Randall; John S Golden; L Julian Haywood
Journal:  Curr Control Trials Cardiovasc Med       Date:  2002-11-14
  7 in total
  3 in total

Review 1.  Moving beyond guidelines: are report cards the answer to high rates of uncontrolled hypertension?

Authors:  Marcel Ruzicka; Frans H H Leenen
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

2.  Results of the Ontario survey on the prevalence and control of hypertension.

Authors:  Frans H H Leenen; Jean Dumais; Natalie H McInnis; Penelope Turton; Lori Stratychuk; Kathleen Nemeth; Margaret Moy Lum-Kwong; George Fodor
Journal:  CMAJ       Date:  2008-05-20       Impact factor: 8.262

3.  Antihypertensive Prescribing for Uncomplicated, Incident Hypertension: Opportunities for Cost Savings.

Authors:  Amity E Quinn; Paul E Ronksley; Lauren Bresee; Flora Au; James Wick; Alexander A Leung; Kerry A McBrien; Braden J Manns; Reed F Beall
Journal:  CJC Open       Date:  2021-01-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.